A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Jul 1997
- 709-11 p. digital